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SUMMARY – Th e aim of the study was to defi ne the eff ects of daily hospice team’s activities on 
depression and anxiety in breast cancer patients having undergone mastectomy after three-month 
therapy. Th is prospective study included 35 patients that underwent mastectomy for breast cancer, 
followed by 3-month treatment at daily hospice, Tuzla University Clinical Center. Control group 
consisted of 35 mastectomized patients that did not visit daily hospice. Depression and anxiety were 
estimated by use of Zung’s scale. Patients were tested initially and retested at 12 weeks. On initial 
testing, the mean value of depression was 59.85±6.97 in the study group and 55.65±7.91 in the con-
trol group. On three-month retesting, the level of depression was lower in the study group, with a 
mean value of 48.57±7.06 (P<0.0001) (steam T-test and Wilcoxon’s test) and higher in the control 
group, with a mean value of 60.45±7.47 (P=0.0001) (steam T-test and Wilcoxon’s test). On initial 
testing, the mean value of anxiety was 54.97±6.35 and 52.20±6.03 in the study and control group, 
respectively. On three-month retesting, the level of anxiety was lower in the study group, with a 
mean value of 43.43±5.97 (P<0.0001), showing improvement from initial testing, but was higher in 
the control group, with a mean value of 55.68±7.47 (P=0.0002). In conclusion, daily hospice team’s 
treatment had favorable eff ects on lowering the levels of depression and anxiety in patients undergo-
ing mastectomy for breast cancer.
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Introduction
Breast cancer is the most common malignant tu-
mor of insidious development. Based on diff erences in 
the rate of newly discovered cases, the risk of breast 
cancer has been classifi ed according to countries as 
follows: 1) high risk countries (northern Europe and 
North America); 2) moderate risk (south Europe and 
South America); and 3) low risk (Asia and Africa)1. 
However, descendents of immigrants coming from 
low risk countries acquire a multiplied risk of devel-
oping breast cancer within three generations, which 
undoubtedly speaks of the eff ect of ecologic factors 
on the breast cancer etiology2. In Bosnia and Herze-
govina, around 1300 women develop breast cancer 
Fig. 1. Incidence of breast cancer in Tuzla Canton
2002-2006.
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and approximately 500 women die from breast cancer 
per year. According to data issued by Tuzla University 
Clinical Center Oncologic Consultation for the 2002-
2006 period, there were 531 newly discovered cases in 
total (Fig. 1), most of them recorded in 2004. 
Every treatment modality for breast cancer has some 
useful eff ects as well as some side eff ects that also in-
fl uence psychosocial morbidity. Surgeons believed that 
tumorectomy would be eff ective treatment and would 
diminish psychiatric morbidity. Nevertheless, at least 
14 published studies compared psychological results 
after mastectomy versus tumorectomy and showed 
that there was little diff erence in psychosocial chang-
es3. Repeat chemotherapy treatment leads to negative 
emotional hair loss, weight gain, skin alteration, nau-
sea, regurgitation, menopausal symptoms, etc., which 
in combination with the fact that surgery alters body 
image strongly infl uence psychological distress4. Al-
teration in body image related to breast cancer treat-
ment (mastectomy, chemotherapy) is a potential source 
of distress5. Looking in the mirror, women conclude 
that they are ugly, less feminine; they see themselves 
through their operation disfi gurement. Many women 
describe alopecia as the most horrible experience in 
their disease and some patients even refuse further 
chemotherapy for this reason. A study including 77 
patients with alopecia due to chemotherapy related to 
mastectomy showed more than 60% (n=47) of patients 
to exhibit signs of anxiety and depression6.
In many tumor types including breast tumor the 
rate of survival has been increasing as the result of 
early detection and improved therapeutic approaches7. 
Th e result is that many patients have to overcome 
physical and emotional consequences of cancer di-
agnosis and unfavorable eff ects of therapeutic treat-
ment. In the last decade, many authors have pointed 
to these groups of patients. Research related to after-
cancer treatment includes monitoring the quality of 
life, depression management, body morbidity, pain, 
and fatigue8. Th ese researches lead to better under-
standing of the psychological and emotional problems 
after cancer treatment and its consequences. Th ese 
programs include post-tumor rehabilitation, psycho-
social interventions, pain management and multidis-
ciplinary programs9.
Patients often speak of emotional problems after 
completing the treatment, predominated by the fol-
lowing feelings: fear of recurrence, inferiority, anxi-
ety, and depression. Th e information collected by 
Payne and Endall suggests the time and space limi-
tation and a limited number of consultants to be the 
greatest obstacle to effi  cient identifi cation of psycho-
logical problems in patients with breast tumor. Th at is 
why they point to the benefi t that patients may gain 
by working in support groups with other patients. Th e 
patients meeting as a group can help each other, pro-
vide valuable assistance to medical professionals, and 
help themselves and other patients10. 
Th e aim of this study was to assess the level of de-
pression and anxiety by use of Zung’s self rating de-
pression scale in patients having undergone mastec-
tomy for breast cancer and having completed specifi c 
oncologic treatment. Patients were tested initially, on 
their fi rst visit to daily hospice, and after three-month 
therapy at daily hospice. 
Patients and Methods 
We prospectively analyzed 70 patients. Study 
group included 35 patients having undergone mastec-
tomy for breast cancer, having completed specifi c on-
cologic treatment (chemotherapy, radiotherapy) and 
visiting our daily hospice (Palliative Care Depart-
ment, Tuzla University Clinical Center) for at least 
12 weeks. Control group consisted of 35 patients that 
had also undergone mastectomy for breast cancer and 
completed specifi c oncologic treatment, but did not 
visit daily hospice for personal reasons (Table 1).
Th e following criteria had to be met to enter the 
study: verifi ed histopathologic diagnosis of breast tu-
mor, followed by operative procedure (mastectomy), 
and completed specifi c oncologic treatment (chemo-
therapy or radiotherapy).
Zung’s self rating scales were used to estimate 
depression and anxiety11,12. Th ese scales consist of 
20 short and simple questions and describe patient 
feeling about particular symptoms. Each question 
is scored on a scale from 1 through 4, ranging from 
‘no or smaller amount of time’ to ‘almost always and 
constantly’. A result of up to 49 points is considered 
normal, 50-59 points indicate minimal to moderate 
depression/anxiety, 60-69 points indicate moderate 
to clear depression/anxiety, and over 70 points indi-
cate severe to extreme depression/anxiety. Patients 
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completed the test independently, with the possible 
unclear questions explained by the physician. Possible 
answers were not suggested in any way.
Physical and psychosocial support for patients in 
daily hospice includes a set up program and engage-
ment of a multidisciplinary team. A physician moni-
tors patient condition during his/her visit, evaluates 
the need for special diagnostic or therapy treatment, 
and along with other medical staff  plans the activities 
of other team members. Individual, group or combined 
treatment by psychotherapists tries to break down any 
mental barriers that could be caused by illness, and 
lower the level of anxiety and depression. Occupa-
tional therapist’s activities are directed to encouraging 
creativity through making simple hand-made objects, 
doing simple jobs or activities in the art room. Physi-
cal therapy includes group and individual, passive and 
active kinetic-therapy exercises, which improve the 
mobility and physical activity of patients, and treats 
lymphostasis as the most common breast cancer com-
plication. Th e advice and specifi c activities of social 
workers help the patients achieve their legal rights. 
Treatment includes transport, lunch and all-day stay 
in specially adapted and adjusted premises.
Statistical processing was done by use of the Med-
Calc for Widows version 9.4.2.0 biomedical applica-
tion software. Comparison was made between the two 
groups of subjects, i.e. patients visiting daily hospice 
and control group of patients that were not treated at 
the hospice. Numerical data were expressed through 
measurements of central tendency and suitable disper-
sion measurements. T-test and Mann-Whitney test 
were used to test the hypothesis of independent sam-
ple concept, between the two groups. Th e χ2-test 2 by 
2 was used to test the hypothesis of diff erence in the 
frequency of parameters of dichotomous scale. Steam 
T-test and Wilcoxon’s test were used to test repeat 
measurement of dependent samples. Th e results were 
comprehensively expressed in charts and appropriate 
graphs. Th e level of signifi cance was set at P<0.05. 
Results 
On initial testing, the mean value of depression 
was 59.85±6.97 in study group and 55.65±7.91 in con-
trol group (minimal to moderate depression). Out of 
70 patients in total, major depression was recorded 
in 57, minimal to mild depression in 35, moderate 
to clear depression in 17, and severe depression in 5 
patients. Repeat testing at three months showed the 
level of depression to have decreased in patients treat-
ed in daily hospice, with a mean value of 48.57±7.06 
(normal fi ndings), which was statistically signifi cantly 
better as compared with initial testing (59.85±6.97; 
minimal to moderate depression; P<0.0001; steam T-
test and Wilcoxon’s test). In control group, however, 
repeat testing showed deterioration of depression with 
a mean value of 60.45±7.47 (clear depression), which 
was signifi cantly worse as compared with initial test-
ing (55.65±7.91; minimal to moderate depression; 
P=0.0001; steam T-test and Wilcoxon’s test) (Fig. 2). 
On initial testing, the mean value of anxiety was 
54.97±6.35 in study group and 52.20±6.03 in control 
group (minimal to moderate anxiety). Out of 70 pa-
tients, overt anxiety was recorded in 55, minimal to 
moderate anxiety in 44, moderate to clear anxiety 
in ten patients, severe anxiety in one patient. Th us, 
minimal to moderate anxiety was most commonly 
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present in breast cancer patients having completed 
specifi c oncologic treatment (Fig. 3). Repeat testing 
at three months showed a lower mean value of anxiety 
of 43.43±5.97 (normal fi ndings) in study group, which 
was statistically signifi cantly better as compared with 
initial testing (54.97±6.35; minimal to moderate anxi-
ety; P<0.0001; steam T-test and Wilcoxon’s test). In 
the control group of patients that did not visit hos-
pice, repeat testing showed a decrease in the level of 
anxiety, with a mean value of 55.68±7.74 (initial test 
52.20±6.03; P=0.002; steam T-test and Wilcoxon’s 
test).
Discussion  
Th ere are reports on the impact of support group 
therapy on survival, prevention and treatment of de-
pression in patients with breast cancer. In the study 
by Kissane et al., 485 women with breast cancer were 
monitored during the 1996-2002 period. Study group 
included 227 women treated by support group thera-
py, whereas control group included 258 women that 
were not included in support group therapy. Support 
group therapy did not increase survival, but decreased 
depression (P=0.002), reduced the feeling of helpless-
ness (P=0.004) and symptoms of trauma (P=0.04), 
and improved social functioning (P=0.03)13. In our 
study, the three-month treatment at daily hospice, 
the multidisciplinary team therapy reduced the lev-
el of depression in women with breast cancer from 
minimum to moderate depression on initial testing 
(59.85±6.97) to normal values on repeat testing three 
months later (48.57±7.06; P<0.0001). However, in the 
control group of patients that did not visit daily hos-
pice repeat testing did not produce as good results and 
reduction in the level of depression (Fig. 2). 
One of the studies reports the effi  cacy of group 
therapy in 154 women with breast cancer. Group 1 
consisted of 54 female patients treated by support 
group therapy (relaxation training, meditation, physi-
cal therapy, emotional expression, and occupational 
therapy); group 2 included 56 patients that refused sup-
port group therapy; and group 3 included 44 patients 
that were not even aware of the existence of this mode 
of therapy. After 4 months, group 1 patients showed 
a signifi cantly reduced feeling of anxiety, concern and 
fear of recurrence, along with emotional well-being 
and improved social function14. In our study, the treat-
ment provided by the multidisciplinary team at daily 
hospice of Tuzla University Clinical Center resulted in 
a reduced level of anxiety in patients with breast can-
cer. Repeat testing after three-month therapy at daily 
hospice showed anxiety reduction from 54.97±6.35 
(minimum to moderate anxiety) to 43.43±5.97 (nor-
mal fi ndings; P<0.0001) (Fig. 3). 
A study conducted in Australia which included 303 
female patients with breast cancer having undergone 
breast surgery and received chemotherapy showed 
10% of patients to have developed severe depression; 
27% less severe depression and 9% a less severe form 
of anxiety. A group of 154 patients included by profes-
sionals in group therapy and conversation with other 
patients showed a lower level of depression and anxi-
ety in comparison to 149 control group patients15. In 
our study, improved results with a signifi cantly lower 
level of anxiety and depression on repeat testing could 
Fig. 2. Depression recorded on fi rst and second testing in 
patient groups.
Fig. 3. Anxiety recorded on fi rst and second testing in 
patient groups.
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also be ascribed to good communication with the pro-
fessional medical staff , group and individual therapies 
with psychotherapists, and mutual support among 
group members. 
Conclusion
Th erapy provided by daily hospice multidisci-
plinary team has a favorable eff ect on diminishing 
depression and anxiety in patients having undergone 
mastectomy for breast cancer. Mutual exercise and in-
dividual treatments by physiatrist and physiotherapist 
as team members improved general physical health, 
while improvement in general mental health was re-
lated to occupational therapy, psychotherapist and 
social worker activities, open conversation between 
patients, and certainty in proper monitoring, follow 
up and counseling by physicians and nurses. Most 
patients felt the daily hospice programs to be par-
ticularly useful for stress management, relaxation and 
recreation, improvement of communication and trust, 
development of self help and self care, and treating 
disease complications such as lymphostasis. 
References
1. FERLAY J, BRAY F, PISANI P, PARKIN DM. Cancer 
incidence, mortality and prevalence worldwide. Lyon: IARC 
Cancer Base, 2004; No. 5, Version 2.0.
2. ADZERSEN KH, EUSTACHI A, GERHARD I. Arbeits-
gemeinschaft Naturheilkunde und Umweltmedizin (NA-
TUM). Stellungnahme zu Umwelt Emahrung und Brust-
krebs. Frauenarzt1999;10:1233-9.
3. FALLOWFIELD LJ, HALL A. MAGUIRE GP, BAUM 
M, A’HERN RP. A question of choice: results of a prospec-
tive 3-year follow-up study of women with breast cancer. 
Breast 1994;3:202-8.
  4. RABINOWITZ B. Two decades of psychosocial research: an 
overview for the practitioner. In: Bonadonna G, Hortobagyi 
G, Gianni AM, eds. Textbook of   breast diseases. London: 
Dunitz, 1997.
  5. NEWELL RJ. Altered body image: a fear-avoidance model 
of psycho-social diffi  culties following disfi gurement. J Adv 
Nurs 1999;30(5):1230-8.
  6. GALLAGHER J. Chemotherapy-induced hair loss: im-
pact on women’s quality of life. Qual Life Nurs Challenge 
1997;5(1-4):75-80.
  7. BRENER H. Long-term survival rates of cancer patients 
achieved by end of the 20th century: a period analysis. Lancet 
2002;360:1131-5.
  8. HJERL K, ANDERSEN EW, KEIDING N. Depression as 
a prognostic factor for breast cancer morbidity. Psychosomat-
ics 2003;44:24-30.
  9. WEERT van E, HOEKSTAWEEBERS JEHM, GROL 
BMF. Physical functioning and quality of life: cancer reha-
bilitation. Int J Rehabil Res 2004;27:27-35.
10. PAYNE S, ENDALL M. Detection of anxiety and depres-
sion by surgeons and signifi cant others in females attending a 
breast clinic. Eur J Oncol Nurs 1998;2(1):4-11. 
11. ZUNG WK. A rating instrument for anxiety disorder. Psy-
chosomatics 1971;12:371-9.
12. ZUNG WK. A self rating depression scale. Arch Gen Psy-
chiatry 1965;12:63-70. 
13. KISSANE DW, GRABSCH B, CLARKE DM, SMITH 
GC, LOVE AW, BLOCH S, SNYDER RD. Supportive-
expressive group therapy for women with metastatic breast 
cancer: survival and psychosocial outcome from a random-
ized controlled trial. Psychooncology 2007;16(4):277-86.
14. CAMERON LD, BOOTH RJ, SCHLATTER M, ZI
GINSKAS D, HARMAN JE. Changes in emotion regula-
tion and psychological adjustment following use of a group 
psychosocial support program for women recently diagnosed 
with breast cancer. Psychooncology 2007;16(3):171-80. 
15. KISSANE DW, BLOCH S, SMITH GC, MIACH P, 
CLARKE DM, IKIN J, LOVE AW, RANIERI N,   McK
ENZIE D. Cognitive-existential group psychotherapy for 
women with primary breast cancer: a randomised controlled 
trial. Psychooncology 2003;12(6):532-46.
Book Acta 1-2010.indb   23 14.6.2010   9:22:52
S. Husić and D. Mešić Daily hospice: depression and anxiety after mastectomy for breast cancer
24 Acta Clin Croat,  Vol. 49,  No. 1,  2010
Sažetak
DNEVNI HOSPICIJ: DEPRESIJA I ANKSIOZNOST NAKON MASTEKTOMIJE ZBOG RAKA DOJKE 
S. Husić i D. Mešić
Cilj studije bio je utvrditi učinak rada tima dnevnog hospicija na depresiju i anksioznost bolesnica s rakom dojke poslije 
mastektomije te nakon tromjesečne terapije. Ova prospektivna studija obuhvatila je 35 bolesnica podvrgnutih mastektomiji 
zbog raka dojke, koje su se liječile u dnevnom hospiciju Kliničkog bolničkog centra Tuzla kroz razdoblje od 12 tjedana. 
Kontrolna skupina sastojala se od 35 bolesnica koje nisu posjećivale dnevni hospicij. Depresija i anksioznost su se procje-
njivale pomoću Zungove ljestvice. Bolesnice su testirane dva puta u 12-tjednom razdoblju. Srednja vrijednost depresije na 
prvom testu bila je 59,85±6,97 u ispitivanoj skupini i 55,65±7,91 u kontrolnoj skupini. Na drugom testu tri mjeseca kasnije 
depresija je bila niža u ispitivanoj skupini, sa srednjom vrijednošću od 48,57±7,06 (P<0,0001) (steam T-test i Wilcoxonov 
test), dok je u kontrolnoj skupini bila viša, sa srednom vrijednošću od 60,45±7,47 (P<0,0001) (steam T-test i Wilcoxonov 
test). Srednja vrijednost za anksioznost na prvom testu bila je 54,97±6,35 u ispitivanoj skupini i 52,20±6,03 u kontrolnoj 
skupini. Drugo testiranje tri mjeseca kasnije pokazalo je bolji rezultat, odnosno nižu razinu anksioznosti u ispitivanoj 
skupini (srednja vrijednost 43,43±5,97; P<0,0001), dok je u kontrolnoj skupini zabilježena viša razina anksioznosti (srednja 
vrijednost 55,68± 7,47; P=0,0002). Zaključuje se kako rad tima u dnevnom hospiciju djeluje povoljno na snižavanje razine 
depresije i anksioznosti kod bolesnica podvrgnutih mastektomiji zbog raka dojke.
Ključne riječi: Anksiozni poremećaji – dijagnostika; Anksiozni poremećaji – epidemiologija; Anksiozni poremećaji – psihologija; 
Novotvorine dojke – psihologija; Mastektomija – psihologija
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